Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Radiation boost for liver cancer immunotherapy?

NCT ID NCT06828380

Summary

This study is testing whether adding a targeted form of radiation therapy (particle beam) to standard immunotherapy helps people with advanced liver cancer that has grown into major blood vessels. It will enroll 128 participants to see if the combination is safe and more effective at controlling the cancer and helping patients live longer without their disease getting worse than immunotherapy alone.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED HEPATOCELLULAR CARCINOMA (HCC) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • National Cancer Center

    RECRUITING

    Goyang, South Korea

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Samsung Medical Center, Seoul

    RECRUITING

    Seoul, South Korea

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.